Merck KGaA (MKGAF)
162.95
+7.50
(+4.82%)
USD |
OTCM |
Oct 06, 16:00
Merck Price : 162.95 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 158.12 | 163.57 | 155.17 | 162.95 | 5115.00 |
| Oct 05, 2026 | 156.27 | 158.70 | 149.17 | 155.45 | 185.00 |
| Oct 02, 2026 | 158.90 | 160.00 | 148.58 | 156.24 | 901.00 |
| Oct 01, 2026 | 149.92 | 159.54 | 149.53 | 149.71 | 198.00 |
| Sep 30, 2026 | 154.77 | 163.93 | 151.69 | 163.93 | 320.00 |
| Sep 29, 2026 | 152.67 | 163.94 | 151.50 | 163.94 | 2816.00 |
| Sep 28, 2026 | 158.53 | 161.00 | 152.38 | 159.51 | 4728.00 |
| Sep 25, 2026 | 158.29 | 159.45 | 151.30 | 159.45 | 72.00 |
| Sep 24, 2026 | 158.35 | 158.70 | 147.64 | 155.12 | 233.00 |
| Sep 23, 2026 | 150.91 | 158.14 | 150.61 | 150.61 | 461.00 |
| Sep 22, 2026 | 158.47 | 158.72 | 148.81 | 149.97 | 347.00 |
| Sep 21, 2026 | 150.03 | 156.45 | 147.53 | 153.71 | 327.00 |
| Sep 18, 2026 | 151.32 | 155.31 | 146.32 | 151.72 | 662.00 |
| Sep 17, 2026 | 155.60 | 155.60 | 150.33 | 150.33 | 306.00 |
| Sep 16, 2026 | 155.79 | 158.06 | 148.29 | 157.05 | 275.00 |
| Sep 15, 2026 | 148.49 | 155.97 | 146.45 | 151.92 | 2100.00 |
| Sep 14, 2026 | 148.90 | 160.00 | 148.90 | 157.36 | 934.00 |
| Sep 11, 2026 | 159.13 | 159.13 | 149.36 | 154.21 | 2661.00 |
| Sep 10, 2026 | 155.80 | 155.80 | 151.66 | 151.95 | 466.00 |
| Sep 09, 2026 | 157.98 | 159.60 | 152.01 | 157.21 | 268.00 |
| Sep 08, 2026 | 153.48 | 163.14 | 153.39 | 155.02 | 341.00 |
| Sep 04, 2026 | 160.61 | 162.61 | 153.89 | 159.12 | 80.00 |
| Sep 03, 2026 | 165.94 | 166.60 | 157.43 | 166.60 | 470.00 |
| Sep 02, 2026 | 166.38 | 167.32 | 163.71 | 163.71 | 214.00 |
| Sep 01, 2026 | 162.60 | 168.86 | 160.88 | 168.41 | 479.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bayer AG | 12.42 |
| Dermapharm Holding SE | 47.69 |
| AstraZeneca PLC | 158.61 |
| GSK Plc | 46.60 |
| Johnson & Johnson | 254.78 |
Price Related Metrics
| PE Ratio | 25.61 |
| PS Ratio | 2.874 |
| Price to Book Value | 2.054 |
| Price to Free Cash Flow | 897.98 |
| Earnings Yield | 3.90% |
| Market Cap | 70.85B |
| Operating PE Ratio | 14.60 |
| Normalized PE Ratio | 21.72 |